Deciphera Pharmaceuticals, Inc. Payments to Acquire Marketable Securities
Deciphera Pharmaceuticals, Inc. reported Payments to Acquire Marketable Securities of $20.26 million for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-10.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireMarketableSecurities · last filed 2024-05-10
- Deciphera Pharmaceuticals, Inc. payments to acquire marketable securities for the quarter ending 2024-03-31 was $20.26M, a 83.51% decline year-over-year.
- Deciphera Pharmaceuticals, Inc. payments to acquire marketable securities for the quarter ending 2023-12-31 was $59.66M, a 27.40% decline year-over-year.
- Deciphera Pharmaceuticals, Inc. payments to acquire marketable securities for the quarter ending 2023-09-30 was $33.78M, a 42.46% decline year-over-year.
- Deciphera Pharmaceuticals, Inc. payments to acquire marketable securities for the quarter ending 2023-06-30 was $106.28M, a 41.57% decline year-over-year.
- Deciphera Pharmaceuticals, Inc. payments to acquire marketable securities for fiscal 2023 was $322.57M, a 0.06% decline from fiscal 2022.
- Deciphera Pharmaceuticals, Inc. payments to acquire marketable securities for fiscal 2022 was $322.77M, a 3.76% decline from fiscal 2021.
- Deciphera Pharmaceuticals, Inc. payments to acquire marketable securities for fiscal 2021 was $335.38M, a 69.42% decline from fiscal 2020.
- Deciphera Pharmaceuticals, Inc. payments to acquire marketable securities for fiscal 2020 was $1.10B, a 34.22% increase from fiscal 2019.
| Period end | Payments to Acquire Marketable Securities 3 month | Payments to Acquire Marketable Securities 6 month | Payments to Acquire Marketable Securities 9 month | Payments to Acquire Marketable Securities 12 month |
|---|---|---|---|---|
| 2024-03-31 | $20.26M 10-Q · filed 2024-05-10 | $79.92M derived: sum of 2 quarters · filed 2024-05-10 | $113.70M derived: sum of 3 quarters · filed 2024-05-10 | $219.98M derived: sum of 4 quarters · filed 2024-05-10 |
| 2023-12-31 | $59.66M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-07 | $93.44M derived: sum of 2 quarters · filed 2024-02-07 | $199.71M derived: sum of 3 quarters · filed 2024-02-07 | $322.57M 10-K · filed 2024-02-07 |
| 2023-09-30 | $33.78M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-30 | $140.06M derived: sum of 2 quarters · filed 2023-10-30 | $262.92M 10-Q · filed 2023-10-30 | $345.09M derived: sum of 4 quarters · filed 2024-05-10 |
| 2023-06-30 | $106.28M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $229.13M 10-Q · filed 2023-08-09 | $311.31M derived: sum of 3 quarters · filed 2024-05-10 | $370.02M derived: sum of 4 quarters · filed 2024-05-10 |
| 2023-03-31 | $122.86M 10-Q · filed 2024-05-10 | $205.03M derived: sum of 2 quarters · filed 2024-05-10 | $263.74M derived: sum of 3 quarters · filed 2024-05-10 | $445.63M derived: sum of 4 quarters · filed 2024-05-10 |
| 2022-12-31 | $82.17M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-07 | $140.88M derived: sum of 2 quarters · filed 2024-02-07 | $322.77M derived: sum of 3 quarters · filed 2024-02-07 | $322.77M 10-K · filed 2024-02-07 |
| 2022-09-30 | $58.71M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-30 | $240.59M derived: sum of 2 quarters · filed 2023-10-30 | $240.59M 10-Q · filed 2023-10-30 | $262.25M derived: sum of 4 quarters · filed 2024-02-07 |
| 2022-06-30 | $181.88M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $181.88M 10-Q · filed 2023-08-09 | $203.54M derived: sum of 3 quarters · filed 2024-02-07 | $305.14M derived: sum of 4 quarters · filed 2024-02-07 |
| 2022-03-31 | $0.00 10-Q · filed 2023-05-03 | $21.66M derived: sum of 2 quarters · filed 2024-02-07 | $123.25M derived: sum of 3 quarters · filed 2024-02-07 | $303.55M derived: sum of 4 quarters · filed 2024-02-07 |
| 2021-12-31 | $21.66M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-07 | $123.25M derived: sum of 2 quarters · filed 2024-02-07 | $303.55M derived: sum of 3 quarters · filed 2024-02-07 | $335.38M 10-K · filed 2024-02-07 |
| 2021-09-30 | $101.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $281.89M derived: sum of 2 quarters · filed 2022-11-03 | $313.72M 10-Q · filed 2022-11-03 | $441.48M derived: sum of 4 quarters · filed 2023-02-07 |
| 2021-06-30 | $180.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $212.12M 10-Q · filed 2022-08-04 | $339.88M derived: sum of 3 quarters · filed 2023-02-07 | $490.71M derived: sum of 4 quarters · filed 2023-02-07 |
| 2021-03-31 | $31.82M 10-Q · filed 2022-05-04 | $159.59M derived: sum of 2 quarters · filed 2023-02-07 | $310.41M derived: sum of 3 quarters · filed 2023-02-07 | $925.07M derived: sum of 4 quarters · filed 2023-02-07 |
| 2020-12-31 | $127.76M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-07 | $278.59M derived: sum of 2 quarters · filed 2023-02-07 | $893.24M derived: sum of 3 quarters · filed 2023-02-07 | $1.10B 10-K · filed 2023-02-07 |
| 2020-09-30 | $150.82M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | $765.48M derived: sum of 2 quarters · filed 2021-11-02 | $969.00M 10-Q · filed 2021-11-02 | $1.17B derived: sum of 4 quarters · filed 2022-02-08 |
| 2020-06-30 | $614.65M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | $818.18M 10-Q · filed 2021-08-03 | $1.02B derived: sum of 3 quarters · filed 2022-02-08 | $1.38B derived: sum of 4 quarters · filed 2022-02-08 |
| 2020-03-31 | $203.53M 10-Q · filed 2021-05-04 | $402.48M derived: sum of 2 quarters · filed 2022-02-08 | $766.91M derived: sum of 3 quarters · filed 2022-02-08 | $841.06M derived: sum of 4 quarters · filed 2022-02-08 |
| 2019-12-31 | $198.95M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-08 | $563.38M derived: sum of 2 quarters · filed 2022-02-08 | $637.53M derived: sum of 3 quarters · filed 2022-02-08 | $817.14M 10-K · filed 2022-02-08 |
| 2019-09-30 | $364.43M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $438.58M derived: sum of 2 quarters · filed 2020-11-05 | $618.19M 10-Q · filed 2020-11-05 | $618.19M derived: sum of 4 quarters · filed 2021-02-09 |
| 2019-06-30 | $74.15M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | $253.76M 10-Q · filed 2020-08-04 | $253.76M derived: sum of 3 quarters · filed 2021-02-09 | |
| 2019-03-31 | $179.61M 10-Q · filed 2020-05-05 | $179.61M derived: sum of 2 quarters · filed 2021-02-09 | ||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-09 | $0.00 10-K · filed 2021-02-09 | ||
| 2018-09-30 | $0.00 10-Q · filed 2019-11-04 | |||
| 2017-12-31 | $0.00 10-K · filed 2020-03-09 |